A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients with Advanced Solid Tumors.

Trial Identifier: D6130C00001
Sponsor: AstraZeneca
NCTID:: NCT02579226
Start Date: October 2015
Primary Completion Date: February 2020
Study Completion Date: April 2020
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version

Trial Locations

Country Location
United States of America, CO Denver, CO, United States of America, 80218
United States of America, FL Sarasota, FL, United States of America, 34232
United States of America, MA Boston, MA, United States of America, 02215
United States of America, TN Nashville, TN, United States of America, 37203
United States of America, TX Houston, TX, United States of America, 77030
United States of America, WI Milwaukee, WI, United States of America, 53226